Back
to sessions
Sep 28
Scientific
MODERATOR(S)
Kenneth Rosenzweig, MD, FASTRO - Icahn School of Medicine at Mount Sinai
Farzan Siddiqui, MD, PhD, MBA, FASTRO - Henry Ford Hospital/Wayne State University
Credits
| AMA PRA Category 1 Credits: | 1.50 |
Presentations
-
01:30pm - 01:40pm ET
Hypofractionated vs. Conventional Fractionated Postmastectomy Radiotherapy in High-Risk Breast Cancer: 10-Year Outcomes from a Phase 3 Randomized Trial
Speaker: Guang-Yi Sun, - Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing -
01:40pm - 01:50pm ET
Initial Results of NRG Oncology NRG-GI003: A Phase III Randomized Trial of Protons versus Photons for Hepatocellular Carcinoma (HCC) (NCT03186898)
Speaker: Theodore Hong, MD - Massachusetts General Hospital, Boston -
01:50pm - 02:00pm ET
SWOG S1827/MAVERICK: A Randomized Phase III Trial of Brain MRI Surveillance with and without Prophylactic Cranial Irradiation (PCI) for Small-Cell Lung Cancer (SCLC)
Speaker: Chad Rusthoven, MD - University of Colorado School of Medicine, Aurora -
02:00pm - 02:10pm ET
Long-Term Impact of Low-Dose Radiotherapy on Disability and Arthroplasty in Knee Osteoarthritis: A 13-Year Randomized Trial
Speaker: Nagendra (Bobby) Koneru, MD, FASTRO - FHN Memorial Hospital, Freeport -
02:10pm - 02:20pm ET
Low-Dose Radiotherapy for Knee Osteoarthritis: Sustained Clinical Benefit and MRI-Confirmed Structural Outcomes from a Randomized Trial
Speaker: Nagendra (Bobby) Koneru, MD, FASTRO - FHN Memorial Hospital, Freeport